Tuesday, July 27, 2010

The Aids2010 Brief

For a long time to come, the Aids2010 would be remembered as one of the most significant HIV/AIDS gatherings. This for me is because of the many scientific breakthroughs presented and discussed at the conference. Many of which now form a new Paradigm for HIV/AIDS prevention and treatment.
Remarkable amongst them is the recorded breakthrough in Microbicides, epitomized by the Caprissa trial's success story. That a gel (Tenofovir Gel) can be used to reduce the transmission of HIV by about 40% is simply awesome. This is a departure from many of the other trials in the past that have not been very promising.
Also, was the highlighting of the importance of circumcision in reducing HIV transmissions by up to 60% was also really interesting.
These and other interesting outcomes, like the drug Raltergavir, which is the pioneer integrase inhibitor and a suitable replacement for the commonly used Protease inhibitors is a positive development. As its lower incidence of Dyslipidemic changes is certainly a plus.
Furthermore, asides the science, the Human Rights dominance in this years conference was worthy of note. With, groups calling for the Decriminalization of Drug use in order to allow the vulnerable groups wherein to come out and be reached, as Intravenous Drug Users' (IDU) HIV incidences continue to rise all over the world especially in Eastern Europe.
Also, there was the issue of Treatment 2.0 . Treatment for Prevention.
These and many more will be shared on this blog to keep alive the spirit of the conference and generate useful discourse that can help bring the lessons learnt from the conference to the fore front of practice, care and the fight against HIV/AIDS.

The Aids2010 Brief

For a long time to come, the Aids2010 would be remember as being one of the most significant of meetings discussing the issue of HIV/AIDS. This for me is because of the many scientific breakthroughs presented and discussed at the conference that now form a new Paradigm for HIV prevention and treatment.
Remarkable amongst them are the recorded breakthroughs in Microbicides, epitomized by the Caprissa trial's success story. That a gel (Tenofovir Gel) can be use to reduce the transmission of HIV by about 40% is simply awesome. This is a depature from many of the other trials in the past that have not been very promising.
Also, was the highlighting of the importance of circumcision in reducing HIV transmissions by up to 60% was also really interesting.
These and other interesting outcomes, like the drug Raltergavir, which is the pioneer integrase inhibitor and a suitable replacement for the commonly used Protease inhibitors is a positive development. As its lower incidence of Dyslipidemic changes is certainly a plus.
Furthermore, asides the science, the Human Rights dominance in this years conference was worthy of note. With, groups calling for the Decriminalization of Drug use in order to allow the vulnerable groups wherein to come out and be reached, as Intravenous Drug Users (IDU) HIV incidences continue to rise all over the world especially in Eastern Europe.
Also, there was the issue of Treatment 2.0 . Treatment for Prevention.
These and many more will be shared on this blog to keep alive the spirit of the conference and generate useful discourse that can help bring the lessons learnt from the conference to the fore front of practice, care and the fight against HIV/AIDS.